Host: Matt Birnholz, MD

Guest: Philip Mease, MD

Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM

Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients.

To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.